References
- Velayos FS, Williamson A, Sousa KH, et al. Early predictors of severe lower gastrointestinal bleeding and adverse outcomes: a prospective study. Clin Gastroenterol Hepatol 2004;2:485-90
- Quirk DM, Barry MJ, Aserkoff B, et al. Physician specialty and variations in the cost of treating patients with acute upper gastrointestinal bleeding. Gastroenterology 1997;113:1443-8
- Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995;90:206-10
- Cagir B. Lower GI bleeding, surgical treatment. http://emedicine.medscape.com/article/195246-overview. Accessed 11/12/2010
- Cryer BL, Wilcox CM, Henk HJ, et al. The economics of upper gastrointestinal bleeding in a US-managed care setting: a retrospective claims-based analysis. J Med Econ 2010;3:70-7
- Wilcox C M, Cryer BL, Henk HJ, et al. Mortality associated with gastrointestinal bleeding events: comparing short-term clinical outcomes of patients hospitalized for upper GI bleeding and acute myocardial infarction in a US managed care setting. Clin Exp Gastroenterol 2009;2: 21-30
- Wilcox CM, Clark WS. Causes and outcome of upper and lower gastrointestinal bleeding: the Grady Hospital experience. South Med J 1999;92:44-50
- Yavorski RT, Wong RK, Maydonovitch C, et al. Analysis of 3,294 causes of upper gastrointestinal bleeding military medical facilities. Am J Gastroenterol 1995;90:568-73
- Prakash C, Zucherman GR. Acute small bowel bleeding: a distinct entity with significantly different economic implications compared with GI bleeding from other locations. Gastrointest Endosc 2003;58:330-5
- Zuckerman GR, Prakash C. Acute lower intestinal bleeding. Part I: clinical presentation and diagnosis. Gastrointest Endosc 1998;48:606-16
- Zuckerman GR, Prakash C. Acute lower intestinal bleeding. Part II: Etiology, therapy, and outcomes. Gastrointest Endosc 1999;49:228-38
- Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717-27
- Champion G, Feng PH, Azuma T, et al. NSAID-induced gastrointestinal damage: epidemiology, risk and prevention with an evaluation of the role of misoprostol: an Asian-Pacific perspective and consensus. Drugs 1997;53:6-19
- Singh G, Ramey DR, Morfeld D, et al. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study. Arch Intern Med 1996;156:1530-6
- Dai C, Stafford RS, Alexander GC. National trends in cyclooxygenase-2 inhibitor use since market release: non-selective diffusion of a selectively cost-effective innovation. Arch Intern Med 2005;165:171-7
- Graham DY, Chan FK. NSAIDs, risks, and gastroprotective strategies: current status and future. Gastroenterology 2008;134:1240-6
- Schünemann HJ, Oxman AD, Vist GE, et al. Interpreting results and drawing conclusions. In: Higgins JPT, Green S (eds), Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0, Chapter 12 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org
- Atkins D, Best D, Briss PA, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations BMJ 2004;328:1490
- Richter JM, Wang TC, Fawaz K, et al. Practice patterns and costs of hospitalization for upper gastrointestinal hemorrhage. J Clin Gastroenterol 1991;13:268-73
- Marshall JK, Collins SM, Gafni A. Prediction of resource utilization and case cost for acute nonvariceal upper gastrointestinal hemorrhage at a Canadian Community Hospital. Am J Gastroenterol 1999;94:1841-6
- Marshall J, Collins S, Gafini A. Demographic predictors of resource utilization for bleeding peptic ulcer disease: The Ontario GI Bleed Study. J Clin Gastroenterol 1999;29:165-70
- Comay D, Marshall JK. Resource utilization for acute lower gastrointestinal hemorrhage: The Ontario GI Bleed Study. Can J Gastroenterol 2002;16: 677-82
- De Leest HTJI, Van Dieten HEM, Van Tulder MW, et al. Costs of treating bleeding and perforated peptic ulcers in the Netherlands. J Rheumatol 2004;31:788-91
- Whelan CT, Chen C, Kaboli P, et al. Upper versus lower gastrointestinal bleeding: a direct comparison of clinical presentation, outcomes, and resource utilization. J Hosp Med 2010;5:141-7
- Bhatt DL, Scheiman J, Abraham NS, et al. American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2008;118:1894-909
- Graham DY, Chan FK. NSAIDs, risks, and gastroprotective strategies: current status and future. Gastroenterology 2008;134:1240-6
- Bjarnason I, Hayllar J, MacPherson AJ, et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832-47
- American College of Rheumatology ad hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs. Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum 2008;59:1058-73
- Schnitzer TJ. Proceedings from the Symposium “The Evolution of Anti-Inflammatory Treatments in Arthritis: Current and Future Perspectives” Update of ACR Guidelines for Osteoarthritis: Role of the Coxibs. J Pain Symptom Manage 2002;23(4S):S24-30
- Morrison A, Moulton K, Clark M, et al. English language restriction when conducting a systematic review-based-meta-analysis: systematic review of published studies. Canadian Agency for Drugs and Technologies in Health, 2009